The US Food and Drug Administration is hosting a one-day virtual public workshop called “Increasing the Efficiency of Biosimilar Development Programs” on September 19 from 9 a.m. to 4 p.m.
This public workshop will focus on statistical, scientific, and clinical methods for streamlining comparative clinical studies associated with biosimilar product development programs.
The workshop is open to the public; however, registration is required.
Leave a Reply